Echo Therapeutics, Inc. (ECTE) Reports Positive Results from Symphony tCGM System Clinical Trial
Echo Therapeutics yesterday announced positive results from its clinical trial of the Symphony tCGM System, a needle-free, noninvasive, wireless, transdermal continuous glucose monitoring system. This study, conducted in 15 elective cardiac surgery patients, has been the first of two studies the company is conducting in critically ill patients; results from the second study are expected later this quarter. As evidenced in data from the study, Symphony successfully and continuously monitored glucose levels in Boston’s Tufts Medical Center cardiothoracic surgical intensive care unit. Data analysis also demonstrated that Symphony was accurate in reading glucose levels, with a mean absolute relative difference,…